Pulmonary angiitis and granulomatosis revisited

doi:10.1016/S0046-8177(83)80162-2

Human Pathology

Volume 14, Issue 10, October 1983, Pages 868-883

https://doi.org/10.1016/S0046-8177(83)80162-2 Get rights and content

Re-examination of the pathologic and clinical features of the entities traditionally classified under the heading “pulmonary angiitis and granulomatosis” indicates that there is little advantage in retaining this artificial category and that these entities should be considered variants of diseases to which they are actually related. Wegener's granulomatosis and allergic angiitis and granulomatosis appear to be examples of true systemic vasculitides in which the lung is a predominant but not the only or even the most important site of involvement. Wegener's granulomatosis may manifest with involvement limited to lung, a form that has been called limited Wegener's; however, many or most such cases progress to classic disease involving kidney and often upper respiratory tract. Similarly, Wegener's granulomatosis may present with disease limited initially to the upper respiratory tract (a form of midline granuloma); this process may also spread to involve lung and kidney. It seems unlikely that limited Wegener's is truly a separate disease category. Evaluation of the pathologic and clinical features of necrotizing sarcoid granulomatosis indicate that it very much resembles ordinary sarcoid in most histologic features, in the nature of extrapulmonary involvement, and in its clinical course and that it probably corresponds to the clinical-radiographic entity of nodular sarcoid. Lymphomatoid granulomatosis appears to have little relationship to the other members of the angiitis and granulomatosis group; its behavior and histologic features are those of a lymphoproliferative disorder that in most cases is or becomes histiocytic lymphoma. Some cases of so-called benign lymphocytic angiitis also fall into this category; the remainder appear to represent a variety of completely unrelated pathologic processes. Last, bronchocentric granulomatosis is most commonly one of the histologic manifestations of allergic bronchopulmonary aspergillosis, although it is likely that other agents or processes produce the same histologic pattern. Although the presence of a common set of pathologic features makes the concept of angiitis and granulomatosis attractive from a morphologic point of view, there is minimal clinical similarity among them, and these diseases appear to be totally separate entities.

References (53)

SaldanaMJ et al.
Pulmonary angiitis and granulomatosis
Hum Pathol
(1977)
ChurgA et al.
Necrotizing sarcoid granulomatosis
Chest
(1979)
KossMN et al.
Bronchocentric granulomatosis
Hum Pathol
(1981)
IsraelHL et al.
Treatment of Wegener's granulomatosis of lung
Am J Med
(1975)
CarringtonCB et al.
Limited forms of angiitis and granulomatosis of Wegener's type
Am J Med
(1966)
LiebowAA et al.
Lymphomatoid granulomatosis
Hum Pathol
(1972)
EichelBS et al.
Primary lymphoma of the nose including relationship to lethal midline granuloma
Am J Surg
(1966)
CassanST et al.
The concept of limited forms of Wegener's granulomatosis
Am J Med
(1970)
SharmaOP et al.
Nodular sarcoidosis: an unusual radiographic appearance
Chest
(1973)
NicholsPW et al.
Lymphomatoid granulomatosis; a T-cell disorder?
Am J Med
(1982)

DeRemeeRA et al.

Wegener's granulomatosis

Mayo Clin Proc

(1976)

Cited by (131)

Mimicking the mimicker: Necrotizing sarcoid granulomatosis
2022, American Journal of the Medical Sciences
Citation Excerpt :
Cough is the most common presentation, followed by chest pain, dyspnea, weight loss, and fatigue. Some do not have symptoms but have abnormal chest radiographs.3 However, unlike GPA, patients with NSG do not have upper airway disease, glomerulonephritis or extra-pulmonary systemic vasculitis.
Necrotizing sarcoid granulomatosis (NSG) is a rare disease that shares similarities with pulmonary vasculitides and sarcoidosis. This is a report of two cases of NSG with a review of literature. The first case is a 33-year-old black female with a one-year history of malaise and cough. Lung imaging revealed scattered pulmonary nodules. Histopathology showed multiple necrotizing granulomas without prominent neutrophilic infiltrates. The second case is a 58-year-old white female with a one-year history of fatigue, dyspnea, and ophthalmoplegia on the left eye. Imaging showed multiple pulmonary nodules. Lung biopsy was consistent with NSG. The challenge of the NSG diagnosis is to distinguish it from other mimickers. Pathology often shows necrotizing granulomatous vasculitis, distinguishing it from classical sarcoid. Laboratory markers for vasculitis like neutrophil cytoplasmic antibodies and antibodies against myeloperoxidase and proteinase 3 are negative or only low titers. NSG responds well to immune-suppression, most commonly with glucocorticoids.
Incidental Lung Cavity in the Heartland
2022, American Journal of the Medical Sciences
Citation Excerpt :
Necrotizing sarcoid granulomatosis (NSG) is histopathologically characterized by the presence of sarcoid-like necrotizing granulomas with evidence of granulomatous vasculitis.7 Some authors have proposed NSG to be a subtype of sarcoidosis known as nodular sarcoidosis (NS).8,9 Since no definitive histopathologic marker for sarcoidosis exists, this opinion has not been universally accepted.10
Necrotizing sarcoid granulomatosis (NSG) is a rare inflammatory disease. Although considered by some to be a subtype of sarcoidosis, this opinion is not universal. NSG is histologically characterized by the presence of necrotizing sarcoid like granuloma and granulomatous vasculitis. The exclusion of potential etiologies for necrotizing granulomatous inflammation is necessary to establish a diagnosis of NSG. A 70-year old female presented to our office after she was incidentally found to have a right lung cavitary lesion on a shoulder X-ray. She had an extensive serologic workup for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, mycobacterial and fungal etiologies, but they were all negative. She subsequently underwent bronchoscopic evaluation and biopsies. The histopathologic analysis revealed sarcoid-like granulomatous inflammation with large necrosis and mild granulomatous vasculitis. The pulmonary function test revealed a restrictive ventilatory defect. The patient was treated with steroid therapy with rapid radiologic and spirometric improvement.
Pulmonary vasculitis and pulmonary hemorrhage
2022, Practical Pulmonary Pathology: A Diagnostic Approach
Inflammation of arteries and veins in the lung can occur in a variety of inflammatory lung diseases. By convention, the term vasculitis is generally restricted to disorders in which vascular inflammation is a major driver of the pathologic process, which is usually immune-mediated. Pulmonary vasculitis and/or capillaritis and diffuse alveolar hemorrhage most commonly occur in the setting of three systemic vasculitic disorders including granulomatosis with polyangiitis (formerly Wegener granulomatosis), eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome), and microscopic polyangiitis. Occasionally, other vasculitic syndromes and systemic connective tissue diseases can involve the lung, including necrotizing sarcoid granulomatosis, giant cell (temporal) arteritis, polyarteritis nodosa, systemic lupus erythematosus, Takayasu arteritis, Goodpasture syndrome (anti-glomerular basement membrane disease), Henoch-Schönlein purpura (IgA vasculitis), and Behçet syndrome, among other miscellaneous and idiopathic conditions. Secondary vasculitis can also occur with pulmonary infections, septic emboli, and classic sarcoidosis. Evaluation of the patient with pulmonary hemorrhage can be a challenge for clinicians, radiologists, and pathologists. In this chapter, the histologic patterns of pulmonary vasculitis and diffuse alveolar hemorrhage are reviewed. A conceptual view of pulmonary hemorrhage is presented for the pathologist from a clinical standpoint, and a morphologic approach to the diagnosis of pulmonary hemorrhage is discussed. Specific disorders associated with vasculitis/capillaritis and diffuse alveolar hemorrhage are reviewed in detail, with clinical features, imaging findings, pathologic findings, and treatments discussed along with important differential diagnostic considerations.
Pulmonary Vasculitis Syndromes
2018, Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series
A rare case of eosinophilic granulomatosis with polyangiitis complicated with progressive pericardial effusion
2017, Journal of Cardiology Cases
A 44-year-old woman had a 15-year history of asthma and had recently been treated for sinusitis and unidentified limb eruption. She had presented at a nearby clinic with inspiratory chest pain one week before hospitalization, and was diagnosed as having eosinophilic pneumonia based on peripheral blood eosinophilia and ground glass opacities in the right lung field, without pericardial effusion, as detected by chest computed tomography. She additionally presented with a feeling of chest tightness, and extensive pericardial effusion appeared within a week. She developed heart failure on admission, and we performed pericardiocentesis. We gave a clinical diagnosis of acute probable myopericarditis as the cause of pericardial effusion based on pleuritic chest pain, pericardial effusion, and elevation of cardiac enzymes, as well as eosinophilic granulomatosis with polyangiitis (EGPA) based on eosinophilia, her history of sinusitis, asthma, and migratory pulmonary opacities. We initiated oral prednisone 25 mg daily and pericardial effusion disappeared. In patients with EGPA, cardiac involvement is more serious than the involvement of other organs, and is associated with a poor prognosis. In this report we describe a rare case of EGPA complicated with progressive pericardial effusion and discuss the importance of the early diagnosis and treatment of EGPA.
<Learning objective: Eosinophilic granulomatosis with polyangiitis (EGPA), or Churg Strauss syndrome, is a multisystem disorder. It is important for patients with EGPA complicated with cardiac involvement to be diagnosed and treated early because cardiac involvement may lead to a fatal outcome.>
Immunologic Nonasthmatic Diseases of the Lung
2014, Middleton's Allergy: Principles and Practice: Eighth Edition

View all citing articles on Scopus

^*: Associate Professor, Department of Pathology, University of British Columbia, 2211 Wesbrook Mall, Vancouver, British Columbia V6T 1W5, Canada.

View full text

Pulmonary angiitis and granulomatosis revisited

Hum Pathol

Chest

Hum Pathol

Am J Med

Am J Med

Hum Pathol

Am J Surg

Am J Med

Chest

Am J Med

Chest